Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Center, Open-Label Trial to Evaluate the Effect of Lifitegrast Ophthalmic Solution 5.0% on Tear Film Biomarkers in Dry Eye Disease

NCT07490535 is registered in ClinicalTrials.gov with Pittsburgh Research Institute as lead sponsor.

NCT NCT07490535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07490535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Center, Open-Label Trial to Evaluate the Effect of Lifitegrast Ophthalmic Solution 5.0% on Tear Film Biomarkers in Dry Eye Disease
Lead sponsor
Pittsburgh Research Institute
Phase
Phase 4
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
November 30, 2026
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome (des), ocular surface disease